Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

5.11
+0.30006.24%
Post-market: 4.72-0.3878-7.59%19:30 EDT
Volume:680.21K
Turnover:3.33M
Market Cap:159.89M
PE:-1.24
High:5.13
Open:4.80
Low:4.69
Close:4.81
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.36
T/O Rate:3.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.73
PE(LYR):-1.79

Loading ...

Neurizon Therapeutics files ASX governance disclosure for 2026

TIPRANKS
·
Aug 25

Prescient Therapeutics Launches Securities Purchase Plan for New Share Issue

TIPRANKS
·
Aug 25

Prescient Therapeutics Launches Share Purchase Plan to Raise Up to AU$7 Million, Shares Fall 7%

MT Newswires Live
·
Aug 25

Tempest Therapeutics Announces New Chief Financial Officer

TIPRANKS
·
Aug 25

Grace Therapeutics Files for Resale of Up to 4.8 Million Shares

MT Newswires Live
·
Aug 25

Grace Therapeutics files to sell 4.76M shares of common stock for holders

TIPRANKS
·
Aug 25

Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Dow Jones
·
Aug 25

Lineage Cell Therapeutics management to meet with B. Riley

TIPRANKS
·
Aug 25

BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline

TIPRANKS
·
Aug 24

Aquestive Therapeutics Price Target Maintained with a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 24

IMPACT Therapeutics to Join Hang Seng Composite Index

MT Newswires Live
·
Aug 24

Aptabio Therapeutics Partially Redeems and Cancels Private Convertible Bonds

TIPRANKS
·
Aug 24

ASX Flags Possible Delisting of Zelira Therapeutics Over Unpaid Listing Fees

TIPRANKS
·
Aug 24

Autolus Therapeutics Earnings Call Highlights Growth Momentum

TIPRANKS
·
Aug 23

Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz

TIPRANKS
·
Aug 22

Silexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal

TIPRANKS
·
Aug 22

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

TIPRANKS
·
Aug 22

Oruka Therapeutics Files $1 Billion Mixed Shelf

MT Newswires Live
·
Aug 22

Stoke Therapeutics Price Target Announced at $40.00/Share by JP Morgan

Dow Jones
·
Aug 22

Craig-Hallum Initiates Quince Therapeutics at Buy With $68 Price Target

MT Newswires Live
·
Aug 21